Financials
- Market Capitalization 1.55 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
—
Rapporto prezzo/fatturato
4.65
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2165 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.42 USD | -5.68% | -2.01% | -12.87% | +62.19% | 1.55 B USD | ||
| 2167 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.75 USD | -0.29% | +0.27% | +35.89% | +151.32% | 1.54 B USD | ||
| 2185 | TYRA Tyra Biosciences, Inc. - Common Stock | 24.91 USD | -4.67% | -4.38% | -20.47% | +73.71% | 1.49 B USD | ||
| 2187 | INVA Innoviva, Inc. - Common Stock | 20.96 USD | 0.00% | -0.52% | -3.68% | +17.62% | 1.51 B USD |